Warren Buffett’s Wisdom Applied: Tarsus Pharmaceuticals Hits Oversold Mark

Legendary investor Warren Buffett famously advises, “Be fearful when others are greedy, and be greedy when others are fearful.” One useful metric for gauging market sentiment is the Relative Strength Index (RSI), a technical analysis indicator that measures momentum on a scale from zero to 100. A stock is typically considered oversold if its RSI falls below 30.

Tarsus Pharmaceuticals Shows Oversold Signals

On Tuesday, shares of Tarsus Pharmaceuticals Inc. (Symbol: TARS) entered oversold territory with an RSI reading of 29.7 after plunging to a low of $40.78 per share. In contrast, the current RSI for the S&P 500 ETF (SPY) stands at 63.4. For bullish investors, TARS’s 29.7 RSI reading may indicate that recent heavy selling is nearing its end, creating potential buying opportunities. Below is the one-year performance chart for TARS shares:

Performance Metrics: A Closer Look

Reviewing the chart, TARS’s 52-week low is $20.0818 per share, while the high is $57.28. The last trade occurred at $41.21, indicating a significant space for potential recovery.

Discover other notable oversold stocks to consider.

Additional Insights:

• ETF Finder
• RMED shares outstanding history
• Funds Holding CSLT

The views and opinions expressed herein belong to the author and do not necessarily reflect those of Nasdaq, Inc.